BEAM vs USB · rev $63.5M vs P/E 12, rev $28.66B
Beam Therapeutics Inc (BEAM) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
BEAM currently screens at market cap $2.01B. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the BEAM and USB stock pages for the full models.
Not investment advice.